TY - JOUR
T1 - Current trends in the management of Gastro-oEsophageal cancers
T2 - Updates to the ESSO core curriculum (ESSO-ETC-UGI-WG initiative)
AU - Herrera Kok, Johnn Henry
AU - Marano, Luigi
AU - van den Berg, Jan Willem
AU - Shetty, Preethi
AU - Vashist, Yogesh
AU - Lorenzon, Laura
AU - Rau, Beate
AU - van Hillegersberg, Richard
AU - de Manzoni, Giovanni
AU - Spallanzani, Andrea
AU - Seo, Won Jun
AU - Nagata, Hiromi
AU - Eveno, Clarisse
AU - Mönig, Stefan
AU - van der Sluis, Karen
AU - Solaini, Leonardo
AU - Wijnhoven, Bas PL
AU - Puccetti, Francesco
AU - Chevallay, Mickael
AU - Lee, Eunju
AU - D'Ugo, Domenico
N1 - Publisher Copyright:
© 2024 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology
PY - 2024/7
Y1 - 2024/7
N2 - Gastro-oEsophageal Cancers (GECs) are severe diseases whose management is rapidly evolving. The European Society of Surgical Oncology (ESSO) is committed to the generation and spread of knowledge, and promotes the multidisciplinary management of cancer patients through its core curriculum. The present work discusses the approach to GECs, including the management of oligometastatic oesophagogastric cancers (OMEC), the diagnosis and management of peritoneal metastases from gastric cancer (GC), the management of Siewert Type II tumors, the importance of mesogastric excision, the role of robotic surgery, textbook outcomes, organ preserving options, the use of molecular markers and immune check-point inhibitors in the management of patients with GECs, as well as the improvement of current clinical practice guidelines for the management of patients with GECs. The aim of the present review is to provide a concise overview of the state-of-the-art on the management of patients with GECs and, at the same time, to share the latest advancements in the field and to foster the debate between surgical oncologists treating GECs worldwide. We are sure that our work will, at the same time, give an update to the advanced surgical oncologists and help the training surgical oncologists to settle down the foundations for their future practice.
AB - Gastro-oEsophageal Cancers (GECs) are severe diseases whose management is rapidly evolving. The European Society of Surgical Oncology (ESSO) is committed to the generation and spread of knowledge, and promotes the multidisciplinary management of cancer patients through its core curriculum. The present work discusses the approach to GECs, including the management of oligometastatic oesophagogastric cancers (OMEC), the diagnosis and management of peritoneal metastases from gastric cancer (GC), the management of Siewert Type II tumors, the importance of mesogastric excision, the role of robotic surgery, textbook outcomes, organ preserving options, the use of molecular markers and immune check-point inhibitors in the management of patients with GECs, as well as the improvement of current clinical practice guidelines for the management of patients with GECs. The aim of the present review is to provide a concise overview of the state-of-the-art on the management of patients with GECs and, at the same time, to share the latest advancements in the field and to foster the debate between surgical oncologists treating GECs worldwide. We are sure that our work will, at the same time, give an update to the advanced surgical oncologists and help the training surgical oncologists to settle down the foundations for their future practice.
KW - EJ junction cancer
KW - Gastric cancer
KW - Multidisciplinary management
KW - oEsophageal cancer
KW - Oligometastatic upper GI cancer
UR - http://www.scopus.com/inward/record.url?scp=85194192456&partnerID=8YFLogxK
U2 - 10.1016/j.ejso.2024.108387
DO - 10.1016/j.ejso.2024.108387
M3 - Review article
C2 - 38796969
AN - SCOPUS:85194192456
SN - 0748-7983
VL - 50
JO - European Journal of Surgical Oncology
JF - European Journal of Surgical Oncology
IS - 7
M1 - 108387
ER -